{"organizations": [], "uuid": "176644323684f6dbeadd8ede257f5d49df16d5d2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-can-fite-biopharma-announces-5-mln/brief-can-fite-biopharma-announces-5-mln-registered-direct-offering-idUSASB0C9P6", "country": "US", "domain_rank": 408, "title": "BRIEF-Can-Fite Biopharma Announces $5 Mln Registered Direct Offering", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.576, "site_type": "news", "published": "2018-03-09T22:08:00.000+02:00", "replies_count": 0, "uuid": "176644323684f6dbeadd8ede257f5d49df16d5d2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-can-fite-biopharma-announces-5-mln/brief-can-fite-biopharma-announces-5-mln-registered-direct-offering-idUSASB0C9P6", "ord_in_thread": 0, "title": "BRIEF-Can-Fite Biopharma Announces $5 Mln Registered Direct Offering", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "fite biopharma ltd", "sentiment": "negative"}, {"name": "ect", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 9, 2018 / 2:08 PM / Updated 9 minutes ago BRIEF-Can-Fite Biopharma Announces $5 Mln Registered Direct Offering Reuters Staff March 9 (Reuters) - Can Fite Biopharma Ltd: * CAN-FITE BIOPHARMA ANNOUNCES $5 MILLION REGISTERED DIRECT OFFERING * CAN FITE BIOPHARMA LTD - WILL ISSUE 3.3 MILLION REGISTERED ADSS OF CAN-FITE AT A PURCHASE PRICE OF $1.50 PER ADS IN A REGISTERED DIRECT OFFERING * CAN FITE BIOPHARMA LTD - ENTERED INTO DEFINITIVE AGREEMENTS WITH INSTITUTIONAL INVESTORS TO RECEIVE GROSS PROCEEDS OF APPROXIMATELY $5 MILLION Source text for Eikon: Further company coverage:", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-09T22:08:00.000+02:00", "crawled": "2018-03-09T16:20:16.124+02:00", "highlightTitle": ""}